Prostate-Specific Membrane Antigen-Based Therapeutics

Prostate-Specific Membrane Antigen-Based Therapeutics

Prostate cancer (PC) is the most common noncutaneous malignancy affecting men in the US, leading to significant morbidity and mortality. While significant therapeutic advances have been made, available systemic therapeutic options are lacking. Prostate-specific membrane antigen (PSMA) is a highly-re...

Full description

Bibliographic Details
Main Authors: Naveed H. Akhtar, Orrin Pail, Ankeeta Saran, Lauren Tyrell, Scott T. Tagawa
Format: Article
Language:English
Published: Hindawi Limited 2012-01-01
Series:Advances in Urology
Online Access:http://dx.doi.org/10.1155/2012/973820

Similar Items

Similar Items